
Histologically Remarkable Eosinophilic Esophagitis Responsive to Dupilumab in a Gastrostomy Tube–Dependent Pediatric Patient on Amino Acid Formula
Author(s) -
Castro Kenny,
Arostegui Dalia,
Schwarz Steven,
Gandhi Sonia,
Peshimam Juveria,
Rabinowitz Simon,
Pittman Meredith,
Wallach Thomas
Publication year - 2022
Publication title -
jpgn reports
Language(s) - English
Resource type - Journals
ISSN - 2691-171X
DOI - 10.1097/pg9.0000000000000250
Subject(s) - eosinophilic esophagitis , medicine , eosinophil , fluticasone , eosinophilic , gastroenterology , esophagus , exacerbation , proton pump inhibitor , dermatology , pathology , asthma , disease
Eosinophilic esophagitis (EoE), an eosinophil predominant, TH2‐mediated condition increasing in prevalence in pediatric and adult populations, is typically treated with dietary manipulations to avoid triggering antigens. However, identifying specific dietary causes remains a persistent challenge, and restrictive diets are burdensome. Total dietary modification using amino acid–based formula does not always produce symptomatic or histologic resolution, suggesting that exposure to ingested aeroallergens drives their disease. EoE patients demonstrate symptomatic exacerbation from July to September correlating with higher grass and ragweed pollen counts. We present a 7‐year‐old tracheostomy‐ and gastrostomy‐dependent girl who was found on surveillance endoscopy to have profound eosinophilic infiltration throughout the esophagus with inflammatory changes including basal cell hyperplasia on histology. She responded partially to topical corticosteroid therapy with fluticasone and had complete resolution of esophageal eosinophilic infiltrate with subcutaneous dupilumab.